Article Details

Long-Acting Antibody Reduces RSV Risk in Infants - Precision Vaccinations

Retrieved on: 2022-03-03 10:38:40

Tags for this article:

Click the tags to see associated articles and topics

Long-Acting Antibody Reduces RSV Risk in Infants - Precision Vaccinations. View article details on hiswai:

Excerpt

U.K.-based AstraZeneca and Sanofi announced today results from the MELODY Phase III trial showed a single dose of the investigational long-acting ...

Article found on: www.precisionvaccinations.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up